{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:11:12Z","timestamp":1791670272320,"version":"4.3.4"},"reference-count":217,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n This first part of the S2k guidelines is an update of the 2015 S1 European guidelines based on the structured assessment of clinically relevant topics by the panel of experts. It is complemented by Part 2, which deals with treatments.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n These guidelines aim to provide the generalist with expert guidance regarding clinically relevant topics such as, for example, diagnosis, clinimetrics and comorbidities.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n The S2k level guidelines signify that they are based on expert consensus. This includes all the topics touched upon, all selected after a Delphi procedure among the experts\/authors and edited into a coherent whole providing an overview of the subject. Certain passages have been adopted without changes from the previous version. The treatment of the disease and potential treatment complications are not included, being beyond the scope of this guidelines part.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Since the S1 guidelines publication, the literature on HS management has grown rapidly, enabling the current revision. The expansion of the guideline is evident and signifies a major leap forward in HS management.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The first part of the guideline for HS provides a consensus\u2010based advice aimed at improving the health care of patients with HS at a generalist level through expert advice.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/jdv.70638","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:13:29Z","timestamp":1787058809000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["European S2k guidelines for hidradenitis suppurativa\/acne inversa Part 1. Epidemiology, diagnosis and clinical assessment"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0712-2540","authenticated-orcid":false,"given":"G. B. E.","family":"Jemec","sequence":"first","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"PHOENIX Research Center, Department of Allergy and Dermatology Herlev\u2010Gentofte University Hospital Gentofte Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5176-2166","authenticated-orcid":false,"given":"B.","family":"Villumsen","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Danish HS Patients' Association Soborg Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3305-3814","authenticated-orcid":false,"given":"K. R.","family":"van Straalen","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermatology Erasmus University Medical Center Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2874-7726","authenticated-orcid":false,"given":"H. H.","family":"van der Zee","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermatology Erasmus University Medical Center Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1219-5928","authenticated-orcid":false,"given":"S.","family":"Valiukevi\u010dien\u0117","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Skin and Venereal Diseases The Hospital of Lithuanian University of Health Sciences Kauno Klinikos Kaunas Lithuania"},{"name":"Department of Skin and Venereal Diseases The Lithuanian University of Health Sciences Kaunas Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Tzellos","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Clinical Medicine UiT\u2014The Arctic University of Norway Troms\u00f8 Norway"},{"name":"Department of Dermatology Nordland Hospital Trust Bod\u00f8 Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Szepietowski","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermato\u2010Venereology 4th Military Hospital Wroclaw Poland"},{"name":"Faculty of Medicine Wroclaw University of Science and Technology Wroclaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Szegedi","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermatology Faculty of Medicine, University of Debrecen Debrecen Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7953-1047","authenticated-orcid":false,"given":"D. M. L.","family":"Saunte","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"PHOENIX Research Center, Department of Allergy and Dermatology Herlev\u2010Gentofte University Hospital Gentofte Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4127-0141","authenticated-orcid":false,"given":"M.","family":"Romanelli","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermatology University of Pisa Pisa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Raynal","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Solidarit\u00e9 Verneuil Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5997-2045","authenticated-orcid":false,"given":"F.","family":"Prignano","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Health Sciences, Section of Dermatology University of Florence Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. P.","family":"Prens","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermatology Erasmus University Medical Center Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Podda","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermatology, Medical Center Klinikum Darmstadt Teaching Hospital Goethe\u2010University Frankfurt Darmstadt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nassif","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Centre d'Infectiologie Necker\u2010Pasteur Institut Pasteur, Centre M\u00e9dical and Universit\u00e9 Paris\u2010Cit\u00e9 Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6882-2113","authenticated-orcid":false,"given":"A.","family":"Molina\u2010Leyva","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermatology and Venereology Hospital Universitario Virgen de Las Nieves \u2013 Ibs Granada Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2067-4929","authenticated-orcid":false,"given":"\u0141.","family":"Matusiak","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermato\u2010Venereology 4th Military Hospital Wroclaw Poland"},{"name":"Faculty of Medicine Wroclaw University of Science and Technology Wroclaw Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8160-4169","authenticated-orcid":false,"given":"A. V.","family":"Marzano","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Dermatology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy"},{"name":"Department of Pathophysiology and Transplantation Universit\u00e0 Degli Studi di Milano Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6995-7714","authenticated-orcid":false,"given":"B. M.","family":"McGrath","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"HS Ireland Hidradenitis Suppurativa Association County Clare Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-8374","authenticated-orcid":false,"given":"A. I.","family":"Liakou","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"1st Department of Dermatology\u2010Venereology \u2018Andreas Sygros\u2019 Hospital for Venereal and Cutaneous Diseases, National and Kapodistrian University of Athens Medical School Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kirby","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Charles Department of Dermatology St Vincent's University Hospital and Charles Institute of Dermatology, University College Dublin Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kem\u00e9ny","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermatology and Allergology University of Szeged Szeged Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Just","sequence":"additional","affiliation":[{"name":"Deutsche Akne Inversa Patientenvereinigung Coesfeld Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8997-9889","authenticated-orcid":false,"given":"D.","family":"Ioannidis","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"1st Department of Dermatology\u2010Venereology Aristotle University Medical School Thessaloniki Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5257-1142","authenticated-orcid":false,"given":"J. R.","family":"Ingram","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Dermatology Department, Division of Infection and Immunity Cardiff University Cardiff UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. E.","family":"Hunger","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermatology, Inselspital Bern University Hospital, University of Bern Bern Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermatology, Center for Blistering Diseases University Medical Center Groningen Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5449-3897","authenticated-orcid":false,"given":"P.","family":"Guillem","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Surgery Clinique du Val d'Ouest Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-4534","authenticated-orcid":false,"given":"\u00d8.","family":"Grimstad","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Clinical Medicine UiT\u2014The Arctic University of Norway Troms\u00f8 Norway"},{"name":"Department of Dermatology Nordland Hospital Trust Bod\u00f8 Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-3911","authenticated-orcid":false,"given":"E. J.","family":"Giamarellos\u2010Bourboulis","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"4th Department of Internal Medicine National and Kapodistrian University of Athens Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2769-8229","authenticated-orcid":false,"given":"M.","family":"Dolenc\u2010Volj\u010d","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Department of Dermatovenereology, Faculty of Medicine University of Ljubljana Ljubljana Slovenia"},{"name":"Department of Dermatovenereology University Medical Centre Ljubljana Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Del Marmol","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Dermatology Unit H\u00f4pital Universitaire de Bruxelles, Universit\u00e9 Libre de Bruxelles Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. Bukvi\u0107","family":"Mokos","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"University of Zagreb School of Medicine Zagreb Croatia"},{"name":"Department of Dermatology and Venereology University Hospital Centre Zagreb Zagreb Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2760-4600","authenticated-orcid":false,"given":"V.","family":"Bettoli","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"HS Clinic, O.U. Of Dermatology Azienda Ospedaliera\u2014University of Ferrara Ferrara Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Benhadou","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Dermatology Unit H\u00f4pital Universitaire de Bruxelles, Universit\u00e9 Libre de Bruxelles Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0418-521X","authenticated-orcid":false,"given":"F. G.","family":"Bechara","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"International Centre for Hidradenitis Suppurativa\/Acne Inversa (ICH), Department of Dermatology Venereology and Allergology, Ruhr\u2010University Bochum Bochum Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1646-2608","authenticated-orcid":false,"given":"C. C.","family":"Zouboulis","sequence":"additional","affiliation":[{"name":"European Hidradenitis Suppurativa Foundation e.V Dessau Germany"},{"name":"Departments of Dermatology, Venereology and Immunology Universitaetsklinikum Ruppin\u2010Brandenburg, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg Neuruppin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"issue":"4","key":"e_1_2_17_2_1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis CC","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"e_1_2_17_3_1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/jdv.20472","article-title":"European S2k guidelines for hidradenitis suppurativa\/acne inversa part 2: treatment","volume":"39","author":"Zouboulis CC","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"e_1_2_17_4_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712_1.x","article-title":"What causes hidradenitis suppurativa?","volume":"17","author":"Kurzen H","year":"2008","journal-title":"Exp Dermatol"},{"issue":"2","key":"e_1_2_17_5_1","first-page":"184","article-title":"Hidradenitis Suppurativa\/acne Inversa: Criteria for diagnosis, severity assessment","volume":"231","author":"Zouboulis CC","year":"2015","journal-title":"Classification and Disease Evaluation Dermatology"},{"issue":"1","key":"e_1_2_17_6_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/derm.2.1.12490","article-title":"Comorbidities of hidradenitis suppurativa (acne inversa)","volume":"2","author":"Fimmel S","year":"2010","journal-title":"Dermatoendocrinol"},{"issue":"12","key":"e_1_2_17_7_1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/exd.14214","article-title":"What causes hidradenitis suppurativa?\u201415\u2009years after","volume":"29","author":"Zouboulis CC","year":"2020","journal-title":"Exp Dermatol"},{"issue":"8","key":"e_1_2_17_8_1","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jamadermatol.2021.1677","article-title":"Prevalence of hidradenitis Suppurativa: A systematic review and meta\u2010regression analysis","volume":"157","author":"Jfri A","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"4","key":"e_1_2_17_9_1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000481836","article-title":"Hidradenitis Suppurativa: An Asian perspective from a Singaporean institute","volume":"4","author":"Choi E","year":"2018","journal-title":"Skin Appendage Disord"},{"issue":"4","key":"e_1_2_17_10_1","first-page":"277","article-title":"Reproductive potential and outcomes in patients with hidradenitis Suppurativa: Clinical profile and therapeutic implications","volume":"11","author":"Montero\u2010Vilchez T","year":"2021","journal-title":"Life (Basel)"},{"issue":"2","key":"e_1_2_17_11_1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000517283","article-title":"Impact of pregnancy on hidradenitis Suppurativa disease course: A systematic review and meta\u2010analysis","volume":"238","author":"Seivright JR","year":"2022","journal-title":"Dermatology"},{"issue":"5","key":"e_1_2_17_12_1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijwd.2020.07.002","article-title":"Menses, pregnancy, delivery, and menopause in hidradenitis suppurativa: A patient survey","volume":"6","author":"Fernandez JM","year":"2020","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"e_1_2_17_13_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaad.2021.05.059","article-title":"Outcomes of pregnancy and childbirth in women with hidradenitis suppurativa","volume":"86","author":"Sakya SM","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_17_14_1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ijwd.2021.10.012","article-title":"Clinical considerations in the management of hidradenitis suppurativa in women","volume":"7","author":"Kozera EK","year":"2021","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"e_1_2_17_15_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.06.023","article-title":"Adverse pregnancy and maternal outcomes in women with hidradenitis suppurativa","volume":"86","author":"Fitzpatrick L","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"e_1_2_17_16_1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamadermatol.2020.5162","article-title":"Pregnancy in hidradenitis Suppurativa\u2010patient perspectives and practice gaps","volume":"157","author":"Adelekun AA","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"8","key":"e_1_2_17_17_1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex\u2010 and age\u2010adjusted population analysis of prevalence estimates for hidradenitis Suppurativa in the United States","volume":"153","author":"Garg A","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"5","key":"e_1_2_17_18_1","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/bjd.13951","article-title":"Hidradenitis suppurativa\u2010acne inversa: A relevant dermatosis in paediatric patients","volume":"173","author":"Bettoli V","year":"2015","journal-title":"Br J Dermatol"},{"issue":"1","key":"e_1_2_17_19_1","first-page":"45","article-title":"Adolescent\u2010onset hidradenitis Suppurativa: Prevalence","volume":"235","author":"Molina\u2010Leyva A","year":"2019","journal-title":"Risk Factors and Disease Features Dermatology"},{"issue":"2","key":"e_1_2_17_20_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/12034754211039993","article-title":"Pediatric hidradenitis Suppurativa: A cross\u2010sectional study on clinical features and treatment approaches","volume":"26","author":"Garcovich S","year":"2022","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"e_1_2_17_21_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamadermatol.2020.5435","article-title":"Hidradenitis Suppurativa in the pediatric population: An international, multicenter, retrospective, cross\u2010sectional study of 481 pediatric patients","volume":"157","author":"Liy\u2010Wong C","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"12","key":"e_1_2_17_22_1","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/jamadermatol.2022.4564","article-title":"Evaluation of hidradenitis Suppurativa diagnostic criteria in pediatric patients","volume":"158","author":"Kittler NW","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"3","key":"e_1_2_17_23_1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjd.21247","article-title":"Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: Results from a multicentre observational study","volume":"187","author":"Di Cesare A","year":"2022","journal-title":"Br J Dermatol"},{"issue":"9","key":"e_1_2_17_24_1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/jamadermatol.2021.2865","article-title":"Differences between children and adults with hidradenitis Suppurativa","volume":"157","author":"Hallock KK","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"6","key":"e_1_2_17_25_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/jdv.15850","article-title":"The patient journey: A voyage from diagnosis to hidradenitis suppurativa multidisciplinary unit","volume":"33","author":"Chiricozzi A","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"e_1_2_17_26_1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/pde.13466","article-title":"Hidradenitis suppurativa in children: The Henry ford experience","volume":"35","author":"Braunberger TL","year":"2018","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"e_1_2_17_27_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.det.2015.08.005","article-title":"Endocrinologic aspects of hidradenitis Suppurativa","volume":"34","author":"Karagiannidis I","year":"2016","journal-title":"Dermatol Clin"},{"issue":"1","key":"e_1_2_17_28_1","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/ajd.13110","article-title":"Hidradenitis suppurativa and polycystic ovarian syndrome: Systematic review and meta\u2010analysis","volume":"61","author":"Phan K","year":"2020","journal-title":"Australas J Dermatol"},{"issue":"6","key":"e_1_2_17_29_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/cjp.cjp_67_21","article-title":"Hidradenitis suppurativa: Disease pathophysiology and sex hormones","volume":"64","author":"Chu CB","year":"2021","journal-title":"Chin J Physiol"},{"issue":"2","key":"e_1_2_17_30_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijwd.2020.02.005","article-title":"Special considerations for women with hidradenitis suppurativa","volume":"6","author":"Collier E","year":"2020","journal-title":"Int J Womens Dermatol"},{"issue":"6","key":"e_1_2_17_31_1","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14219","article-title":"Increased prevalence of family history of Alzheimer's disease in hidradenitis suppurativa: Cross\u2010sectional analysis of 192 HS patients","volume":"33","author":"Esme P","year":"2020","journal-title":"Dermatol Ther"},{"issue":"2","key":"e_1_2_17_32_1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clindermatol.2020.10.016","article-title":"PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa","volume":"39","author":"Garcovich S","year":"2021","journal-title":"Clin Dermatol"},{"key":"e_1_2_17_33_1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.12688\/f1000research.52100.2","article-title":"Case report: PsAPSASH syndrome: An alternative phenotype of syndromic hidradenitis suppurativa treated with the IL\u201017A inhibitor secukinumab","volume":"10","author":"Nikolakis G","year":"2021","journal-title":"F1000Res"},{"issue":"5","key":"e_1_2_17_34_1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjd.20954","article-title":"New insights in hidradenitis suppurativa from a population\u2010based Dutch cohort: Prevalence, smoking behaviour, socioeconomic status and comorbidities","volume":"186","author":"Prens LM","year":"2022","journal-title":"Br J Dermatol"},{"issue":"12","key":"e_1_2_17_35_1","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/ijd.16163","article-title":"Hidradenitis suppurativa: Racial and socioeconomic considerations in management","volume":"61","author":"Choi ECE","year":"2022","journal-title":"Int J Dermatol"},{"issue":"4","key":"e_1_2_17_36_1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jaad.2016.04.067","article-title":"Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross\u2010sectional reference study","volume":"75","author":"Deckers IE","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"e_1_2_17_37_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000508528","article-title":"Thyroid disease and active smoking may Be associated with more severe hidradenitis Suppurativa: Data from a prospective cross sectional single\u2010center study","volume":"237","author":"Liakou AI","year":"2021","journal-title":"Dermatology"},{"issue":"5","key":"e_1_2_17_38_1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000505149","article-title":"Clinical pearls for managing hidradenitis Suppurativa patients of low socioeconomic status","volume":"236","author":"McKenzie SA","year":"2020","journal-title":"Dermatology"},{"issue":"2","key":"e_1_2_17_39_1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the global survey of impact and healthcare needs (VOICE) project","volume":"82","author":"Garg A","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"e_1_2_17_40_1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamadermatol.2014.691","article-title":"Health care utilization patterns and costs for patients with hidradenitis suppurativa","volume":"150","author":"Kirby JS","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"4","key":"e_1_2_17_41_1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaad.2009.09.021","article-title":"Hidradenitis suppurativa markedly decreases quality of life and professional activity","volume":"62","author":"Matusiak \u0141","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"e_1_2_17_42_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/bjd.17101","article-title":"Impact of hidradenitis suppurativa on work loss, indirect costs and income","volume":"181","author":"Tzellos T","year":"2019","journal-title":"Br J Dermatol"},{"issue":"6","key":"e_1_2_17_43_1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jaad.2017.07.027","article-title":"Uncovering burden disparity: A comparative analysis of the impact of moderate\u2010to\u2010severe psoriasis and hidradenitis suppurativa","volume":"77","author":"Hamzavi IH","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"e_1_2_17_44_1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2340\/00015555-3012","article-title":"Achieving hidradenitis Suppurativa response score is associated with significant improvement in clinical and patient\u2010reported outcomes: Post hoc analysis of pooled data from PIONEER I and II","volume":"98","author":"Kimball AB","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"e_1_2_17_45_1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly MC","year":"1993","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"e_1_2_17_46_1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/jdv.16726","article-title":"Sexual impairment in patients with hidradenitis suppurativa: A systematic review","volume":"35","author":"Cuenca\u2010Barrales C","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"e_1_2_17_47_1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","article-title":"Profound disturbances of sexual health in patients with acne inversa","volume":"67","author":"Kurek A","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"e_1_2_17_48_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijwd.2017.10.007","article-title":"Quality of life and sexual health in patients with hidradenitis suppurativa","volume":"4","author":"Alavi A","year":"2018","journal-title":"Int J Womens Dermatol"},{"issue":"8","key":"e_1_2_17_49_1","first-page":"61","article-title":"Sexual dysfunction in patients with hidradenitis Suppurativa: A systematic review and meta\u2010analysis","volume":"14","author":"Seetan K","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"e_1_2_17_50_1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8040532","article-title":"Sexual distress in patients with hidradenitis Suppurativa: A cross\u2010sectional study","volume":"8","author":"Cuenca\u2010Barrales C","year":"2019","journal-title":"J Clin Med"},{"issue":"3","key":"e_1_2_17_51_1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2340\/00015555-1082","article-title":"Psychosocial impact of hidradenitis suppurativa: A qualitative study","volume":"91","author":"Esmann S","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"e_1_2_17_52_1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"Von Der Werth JM","year":"2001","journal-title":"Br J Dermatol"},{"issue":"4","key":"e_1_2_17_53_1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","article-title":"Quality of life impairment in hidradenitis suppurativa: A study of 61 cases","volume":"56","author":"Wolkenstein P","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"e_1_2_17_54_1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2340\/00015555-2308","article-title":"Pain in hidradenitis Suppurativa: A pilot study","volume":"96","author":"Ring HC","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"e_1_2_17_55_1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2340\/00015555-2815","article-title":"Clinical characteristics of pruritus and pain in patients with hidradenitis Suppurativa","volume":"98","author":"Matusiak \u0141","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"13","key":"e_1_2_17_56_1","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.3390\/ijerph18136709","article-title":"The burden of hidradenitis Suppurativa signs and symptoms in quality of life: Systematic review and meta\u2010analysis","volume":"18","author":"Montero\u2010Vilchez T","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"e_1_2_17_57_1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/bjd.18656","article-title":"Pain perception in patients with hidradenitis suppurativa","volume":"182","author":"Nielsen RM","year":"2020","journal-title":"Br J Dermatol"},{"issue":"8","key":"e_1_2_17_58_1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2340\/00015555-2967","article-title":"Influence of itch and pain on sleep quality in patients with hidradenitis Suppurativa","volume":"98","author":"Kaaz K","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"e_1_2_17_59_1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000453355","article-title":"Quality of life and psychosocial implications in patients with hidradenitis Suppurativa","volume":"232","author":"Kouris A","year":"2017","journal-title":"Dermatology"},{"issue":"4","key":"e_1_2_17_60_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamadermatol.2017.6058","article-title":"Association of Hidradenitis Suppurativa with Body Image","volume":"154","author":"Schneider\u2010Burrus S","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"4","key":"e_1_2_17_61_1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00403-022-02412-5","article-title":"Stigmatization, a social perception which may have a debilitating impact on hidradenitis suppurativa patients: An observational study","volume":"315","author":"Singh R","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"e_1_2_17_62_1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","article-title":"Psychophysical aspects of hidradenitis suppurativa","volume":"90","author":"Matusiak \u0141","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_17_63_1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2147\/CCID.S180036","article-title":"Perspectives on perceived stigma and self\u2010stigma in patients with hidradenitis Suppurativa","volume":"12","author":"Koumaki D","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"e_1_2_17_64_1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjd.12787","article-title":"The prevalence of inverse recurrent suppuration: A population\u2010based study of possible hidradenitis suppurativa","volume":"170","author":"Vinding GR","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"e_1_2_17_65_1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjd.18660","article-title":"A narrative review of the definition of \u201cflare\u201d in hidradenitis suppurativa","volume":"182","author":"Kirby JS","year":"2020","journal-title":"Br J Dermatol"},{"issue":"5","key":"e_1_2_17_66_1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/bjd.21647","article-title":"International consensus definition of disease flare in hidradenitis suppurativa","volume":"187","author":"LeWitt TM","year":"2022","journal-title":"Br J Dermatol"},{"issue":"1","key":"e_1_2_17_67_1","first-page":"218","article-title":"Periodic worsening, or flare, in hidradenitis suppurativa: The perspective of people with hidradenitis","volume":"182","author":"Sarfo A","year":"2020","journal-title":"Br J Dermatol"},{"issue":"5","key":"e_1_2_17_68_1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jbspin.2017.09.005","article-title":"Association between hidradenitis suppurativa and spondyloarthritis","volume":"85","author":"Fauconier M","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"4","key":"e_1_2_17_69_1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.semarthrit.2018.03.010","article-title":"High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra\u2010articular manifestation","volume":"48","author":"Rondags A","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"e_1_2_17_70_1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1159\/000514582","article-title":"Association between hidradenitis Suppurativa and inflammatory arthritis: A systematic review and meta\u2010analysis","volume":"237","author":"Almuhanna N","year":"2021","journal-title":"Dermatology"},{"issue":"5","key":"e_1_2_17_71_1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjd.14024","article-title":"Cardiovascular disease risk factors in patients with hidradenitis suppurativa: A systematic review and meta\u2010analysis of observational studies","volume":"173","author":"Tzellos T","year":"2015","journal-title":"Br J Dermatol"},{"issue":"4","key":"e_1_2_17_72_1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all\u2010cause mortality in patients with hidradenitis Suppurativa","volume":"152","author":"Egeberg A","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"5","key":"e_1_2_17_73_1","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/bjd.15458","article-title":"Interleukin\u201032 is highly expressed in lesions of hidradenitis suppurativa","volume":"177","author":"Thomi R","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"e_1_2_17_74_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence\u2010based consensus on the diagnosis and Management of Crohn's disease 2016: Part 1: Diagnosis and medical management","volume":"11","author":"Gomoll\u00f3n F","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"9","key":"e_1_2_17_75_1","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamadermatol.2019.0891","article-title":"Association of Hidradenitis Suppurativa with Inflammatory Bowel Disease","volume":"155","author":"Chen WT","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"7","key":"e_1_2_17_76_1","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00384-019-03313-2","article-title":"High prevalence of hidradenitis suppurativa in patients with perianal fistula","volume":"34","author":"Ardon CB","year":"2019","journal-title":"Int J Color Dis"},{"key":"e_1_2_17_77_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/exd.14633","article-title":"Which hidradenitis suppurativa comorbidities should I take into account?","volume":"31","author":"Tzellos T","year":"2022","journal-title":"Exp Dermatol"},{"issue":"2","key":"e_1_2_17_78_1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jdv.14599","article-title":"Low and high body mass index in hidradenitis suppurativa patients\u2014different subtypes?","volume":"32","author":"Theut Riis P","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"e_1_2_17_79_1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaad.2019.08.034","article-title":"Association between obesity and hidradenitis suppurativa among children and adolescents: A population\u2010based analysis in the United States","volume":"82","author":"Balgobind A","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"e_1_2_17_80_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.det.2015.08.011","article-title":"The role of mechanical stress in hidradenitis Suppurativa","volume":"34","author":"Boer J","year":"2016","journal-title":"Dermatol Clin"},{"issue":"3","key":"e_1_2_17_81_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00403-019-02012-w","article-title":"Serum IL\u201036\u03b1, IL\u201036\u03b2, and IL\u201036\u03b3 levels in patients with hidradenitis suppurativa: Association with disease characteristics, smoking, obesity, and metabolic syndrome","volume":"312","author":"Hayran Y","year":"2020","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"e_1_2_17_82_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","article-title":"Incidence of hidradenitis suppurativa and associated factors: A population\u2010based study of Olmsted County","volume":"133","author":"Vazquez BG","year":"2013","journal-title":"Minnesota J Invest Dermatol"},{"issue":"4","key":"e_1_2_17_83_1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa","volume":"27","author":"Onderdijk AJ","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"e_1_2_17_84_1","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1080\/09546634.2021.1937483","article-title":"Psychosocial impact of hidradenitis suppurativa: A practical guide for clinicians","volume":"33","author":"Weigelt MA","year":"2022","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"e_1_2_17_85_1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00403-022-02391-7","article-title":"Hidradenitis suppurativa and suicide risk: A multivariate analysis in a disease with a high psychological burden","volume":"315","author":"Ortiz\u2010\u00c1lvarez J","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"e_1_2_17_86_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ad.2022.08.016","article-title":"Pain and late\u2010onset of hidradenitis suppurativa can have a negative influence on occupational status and educational level","volume":"114","author":"Barboza\u2010Guadagnini L","year":"2023","journal-title":"A Cross\u2010Sectional Study Actas Dermosifiliogr"},{"issue":"3","key":"e_1_2_17_87_1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/jdv.15997","article-title":"Hidradenitis suppurativa and schizophrenia: A nationwide cohort study","volume":"34","author":"Tzur Bitan D","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"e_1_2_17_88_1","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/jdv.15071","article-title":"Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: A nationwide population\u2010based study","volume":"32","author":"Lee JH","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"e_1_2_17_89_1","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jaad.2019.05.093","article-title":"Increased risk of alopecia areata for people with hidradenitis suppurativa in a cross\u2010sectional study","volume":"81","author":"Horissian M","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"e_1_2_17_90_1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jamadermatol.2019.2610","article-title":"Incidence of long\u2010term opioid use among opioid\u2010naive patients with hidradenitis Suppurativa in the United States","volume":"155","author":"Reddy S","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"2","key":"e_1_2_17_91_1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/ijd.14651","article-title":"Psoriasis as a comorbidity of hidradenitis suppurativa","volume":"59","author":"Kj\u00e6rsgaard Andersen R","year":"2020","journal-title":"Int J Dermatol"},{"issue":"5","key":"e_1_2_17_92_1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2015.07.055","article-title":"Systemic associations of hidradenitis suppurativa","volume":"73","author":"Kohorst JJ","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"e_1_2_17_93_1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/ijd.16409","article-title":"Long\u2010term risk of death in patients with hidradenitis suppurativa","volume":"62","author":"Kohorst JJ","year":"2023","journal-title":"Int J Dermatol"},{"issue":"6","key":"e_1_2_17_94_1","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/bjd.17578","article-title":"Substantially reduced life expectancy in patients with hidradenitis suppurativa: A Finnish nationwide registry study","volume":"180","author":"Tiri H","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"e_1_2_17_95_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jdv.14517","article-title":"Recommendations for the management of comorbidity in hidradenitis suppurativa","volume":"32","author":"Dauden E","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"e_1_2_17_96_1","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2021.01.059","article-title":"Comorbidity screening in hidradenitis suppurativa: Evidence\u2010based recommendations from the US and Canadian hidradenitis Suppurativa foundations","volume":"86","author":"Garg A","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"e_1_2_17_97_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jama.1968.03140010021004","article-title":"Hidradenitis suppurativa","volume":"203","author":"Knaysi GA","year":"1968","journal-title":"JAMA"},{"issue":"4","key":"e_1_2_17_98_1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: Results from two case\u2010control studies","volume":"59","author":"Revuz JE","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"e_1_2_17_99_1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius K","year":"2009","journal-title":"Br J Dermatol"},{"issue":"4","key":"e_1_2_17_100_1","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1111\/jdv.18702","article-title":"Passive smoking and hidradenitis suppurativa: A retrospective analysis","volume":"37","author":"Apar\u00edcio Martins I","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"e_1_2_17_101_1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jdermsci.2017.04.006","article-title":"A retrospective institutional study of the association of smoking with the severity of hidradenitis suppurativa","volume":"87","author":"Dessinioti C","year":"2017","journal-title":"J Dermatol Sci"},{"issue":"4","key":"e_1_2_17_102_1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjd.13090","article-title":"Risk factors, clinical course and long\u2010term prognosis in hidradenitis suppurativa: A cross\u2010sectional study","volume":"171","author":"Kromann CB","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"e_1_2_17_103_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2016.07.041","article-title":"The effect of smoking and age on the response to first\u2010line therapy of hidradenitis suppurativa: An institutional retrospective cohort study","volume":"76","author":"Denny G","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"24","key":"e_1_2_17_104_1","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.lfs.2007.02.007","article-title":"Functional significance of non\u2010neuronal acetylcholine in skin epithelia","volume":"80","author":"Hana A","year":"2007","journal-title":"Life Sci"},{"key":"e_1_2_17_105_1","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.3389\/fmicb.2018.02575","article-title":"Nicotine enhances Staphylococcus epidermidis biofilm formation by altering the bacterial autolysis, extracellular DNA releasing, and polysaccharide intercellular Adhesin production","volume":"9","author":"Wu Y","year":"2018","journal-title":"Front Microbiol"},{"issue":"9","key":"e_1_2_17_106_1","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/exd.14173","article-title":"Targeting the \u03b17 nicotinic acetylcholine receptor\u2010a novel road towards the future treatment of skin diseases","volume":"29","author":"Stegemann A","year":"2020","journal-title":"Exp Dermatol"},{"issue":"11","key":"e_1_2_17_107_1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.it.2020.09.007","article-title":"Polyamines and kynurenines at the intersection of immune modulation","volume":"41","author":"Proietti E","year":"2020","journal-title":"Trends Immunol"},{"issue":"1","key":"e_1_2_17_108_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000503153","article-title":"Hidradenitis Suppurativa or hidradenitis Suppurativa\u2010like lesions located on amputation stumps? Description of 2 cases","volume":"6","author":"Kluger N","year":"2020","journal-title":"Skin Appendage Disord"},{"key":"e_1_2_17_109_1","unstructured":"HISTORICgroup (Hidradenitis Suppurativa Core Outcomes Set International Collaboration).https:\/\/www.c3outcomes.org\/historic"},{"issue":"3","key":"e_1_2_17_110_1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.16672","article-title":"A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process","volume":"179","author":"Thorlacius L","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"e_1_2_17_111_1","first-page":"32","article-title":"Management of patients with hidradenitis suppurativa","volume":"107","author":"Martorell A","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"e_1_2_17_112_1","unstructured":"HurleyHE.Axillary hyperhidrosis apocrine bromhidrosis hidradenitis suppurativa and familial benign pemphigus: Surgical approach.1989In: Roenigk R.K. & Roenigk R.H. eds. Dermatologic Surgery New York: Marcel Dekker. p.729\u2013739."},{"issue":"3","key":"e_1_2_17_113_1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/bjd.17716","article-title":"Inter\u2010rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa","volume":"181","author":"Thorlacius L","year":"2019","journal-title":"Br J Dermatol"},{"issue":"3","key":"e_1_2_17_114_1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2340\/00015555-2513","article-title":"Hurley staging refined: A proposal by the Dutch hidradenitis Suppurativa expert group","volume":"97","author":"Horv\u00e1th B","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"e_1_2_17_115_1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/bjd.17508","article-title":"Correlation of the refined Hurley classification for hidradenitis suppurativa with patient\u2010reported quality of life and objective disease severity assessment","volume":"180","author":"Rondags A","year":"2019","journal-title":"Br J Dermatol"},{"issue":"5","key":"e_1_2_17_116_1","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/bjd.15748","article-title":"Development and validation of the international hidradenitis Suppurativa severity score system (IHS4), a novel dynamic scoring system to assess HS severity","volume":"177","author":"Zouboulis CC","year":"2017","journal-title":"Br J Dermatol"},{"issue":"5","key":"e_1_2_17_117_1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/pde.15026","article-title":"A cross\u2010sectional study of pediatric hidradenitis suppurativa and the value of the international hidradenitis Suppurativa severity score system (IHS4) as a pediatric clinical trial inclusion criteria","volume":"39","author":"Bui H","year":"2022","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"e_1_2_17_118_1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/jdv.16183","article-title":"Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study","volume":"34","author":"Martorell A","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"e_1_2_17_119_1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/bjd.17982","article-title":"Inter\u2010rater and intrarater agreement and reliability in clinical staging of hidradenitis suppurativa\/acne inversa","volume":"181","author":"Zouboulis CC","year":"2019","journal-title":"Br J Dermatol"},{"issue":"2","key":"e_1_2_17_120_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/bjd.21236","article-title":"Development and initial validation of the HS\u2010IGA: A novel hidradenitis suppurativa\u2010specific investigator global assessment for use in interventional trials","volume":"187","author":"Garg A","year":"2022","journal-title":"Br J Dermatol"},{"issue":"3","key":"e_1_2_17_121_1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jamadermatol.2017.5890","article-title":"A novel severity assessment scoring system for hidradenitis Suppurativa","volume":"154","author":"Hessam S","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"5","key":"e_1_2_17_122_1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/bjd.19565","article-title":"Hidradenitis Suppurativa area and severity index revised (HASI\u2010R): Psychometric property assessment","volume":"184","author":"Goldfarb N","year":"2021","journal-title":"Br J Dermatol"},{"issue":"4","key":"e_1_2_17_123_1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","article-title":"Translating the science of quality of life into practice: What do dermatology life quality index scores mean?","volume":"125","author":"Hongbo Y","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"2","key":"e_1_2_17_124_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/bjd.18692","article-title":"The hidradenitis Suppurativa quality of life (HiSQOL) score: Development and validation of a measure for clinical trials","volume":"183","author":"Kirby JS","year":"2020","journal-title":"Br J Dermatol"},{"issue":"4","key":"e_1_2_17_125_1","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/bjd.14975","article-title":"Sexual health and quality of life are impaired in hidradenitis suppurativa: A multicentre cross\u2010sectional study","volume":"176","author":"Janse IC","year":"2017","journal-title":"Br J Dermatol"},{"issue":"4","key":"e_1_2_17_126_1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2340\/00015555-2561","article-title":"Impairment of sexual life in 3485 dermatological outpatients from a multicentre study in 13 European countries","volume":"97","author":"Sampogna F","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"e_1_2_17_127_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000481117","article-title":"Health\u2010related quality of life of patients with hidradenitis Suppurativa measured with the 15D instrument and comparison with the general population and patients with psoriasis","volume":"4","author":"Kluger N","year":"2018","journal-title":"Skin Appendage Disord"},{"issue":"5","key":"e_1_2_17_128_1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40257-017-0280-2","article-title":"Assessing pruritus in hidradenitis Suppurativa: A cross\u2010sectional study","volume":"18","author":"Vossen ARJV","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"e_1_2_17_129_1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjd.19344","article-title":"Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa","volume":"184","author":"Kirby JS","year":"2021","journal-title":"Br J Dermatol"},{"issue":"6","key":"e_1_2_17_130_1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/bjd.21821","article-title":"Pain measurement in painful skin conditions and rheumatoid arthritis randomized controlled trials: A scoping review to inform pain measurement in hidradenitis suppurativa","volume":"187","author":"Hasan SB","year":"2022","journal-title":"Br J Dermatol"},{"issue":"6","key":"e_1_2_17_131_1","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaad.2018.05.015","article-title":"Adalimumab alleviates skin pain in patients with moderate\u2010to\u2010severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials","volume":"79","author":"Kimball AB","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"e_1_2_17_132_1","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/jdv.15710","article-title":"Ultrasound as a diagnostic and management tool in hidradenitis suppurativa patients: A multicentre study","volume":"33","author":"Martorell A","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"e_1_2_17_133_1","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/dsu.12329","article-title":"Ultrasound in\u2010depth characterization and staging of hidradenitis suppurativa","volume":"39","author":"Wortsman X","year":"2013","journal-title":"Dermatol Surg"},{"issue":"4","key":"e_1_2_17_134_1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/srt.12823","article-title":"Advanced evaluation of hidradenitis suppurativa with ultra\u2010high frequency ultrasound: A promising tool for the diagnosis and monitoring of disease progression","volume":"26","author":"Oranges T","year":"2020","journal-title":"Skin Res Technol"},{"issue":"6","key":"e_1_2_17_135_1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1684\/ejd.2018.3430","article-title":"Comparison of clinical and sonographic scores in a cohort of 140 patients with hidradenitis suppurativa from an Italian referral centre: A retrospective observational study","volume":"28","author":"Nazzaro G","year":"2018","journal-title":"Eur J Dermatol"},{"issue":"2","key":"e_1_2_17_136_1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/ced.14889","article-title":"Assessment of inter\u2010rater reliability of clinical hidradenitis suppurativa outcome measures using ultrasonography","volume":"47","author":"Lyons AB","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"e_1_2_17_137_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.det.2015.08.003","article-title":"Imaging of hidradenitis Suppurativa","volume":"34","author":"Wortsman X","year":"2016","journal-title":"Dermatol Clin"},{"issue":"2","key":"e_1_2_17_138_1","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14804","article-title":"Clinical and power\u2010Doppler ultrasound features related with persistence of fistulous tracts under treatment with adalimumab in hidradenitis suppurativa: 4\u2009years of follow\u2010up","volume":"34","author":"Caposiena Caro RD","year":"2021","journal-title":"Dermatol Ther"},{"issue":"3","key":"e_1_2_17_139_1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/srt.12805","article-title":"Ultrasonographic assessment of fibrosis in hidradenitis suppurativa fistulae helps in addressing treatment","volume":"26","author":"Nazzaro G","year":"2020","journal-title":"Skin Res Technol"},{"issue":"6","key":"e_1_2_17_140_1","first-page":"830","article-title":"Color Doppler as a tool for correlating vascularization and pain in hidradenitis suppurativa lesions","volume":"25","author":"Nazzaro G","year":"2019","journal-title":"Skin Res Technol"},{"issue":"1","key":"e_1_2_17_141_1","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14706","article-title":"Vascularization and fibrosis are important ultrasonographic tools for assessing response to adalimumab in hidradenitis suppurativa: Prospective study of 32 patients","volume":"34","author":"Nazzaro G","year":"2021","journal-title":"Dermatol Ther"},{"issue":"4","key":"e_1_2_17_142_1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/bjd.19343","article-title":"Doppler ultrasound\u2010based noninvasive biomarkers in hidradenitis suppurativa: Evaluation of analytical and clinical validity","volume":"184","author":"Grand D","year":"2021","journal-title":"Br J Dermatol"},{"issue":"4","key":"e_1_2_17_143_1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bjd.19433","article-title":"Strong validation of ultrasound as an imaging biomarker in hidradenitis suppurativa","volume":"184","author":"Wortsman X","year":"2021","journal-title":"Br J Dermatol"},{"issue":"3","key":"e_1_2_17_144_1","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jaad.2022.08.064","article-title":"Ultrasonographic railway sign in tunnels as a new independent risk factor of adalimumab failure in hidradenitis suppurativa","volume":"88","author":"Krajewski PK","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"e_1_2_17_145_1","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15068","article-title":"Ultrasound\u2010guided injection of intralesional steroids in acute hidradenitis suppurativa lesions: A prospective study","volume":"34","author":"Iannone M","year":"2021","journal-title":"Dermatol Ther"},{"issue":"10","key":"e_1_2_17_146_1","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/jdv.16435","article-title":"Pre\u2010operative ultrasound planning in the surgical management of patients with hidradenitis suppurativa","volume":"34","author":"Cuenca\u2010Barrales C","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"e_1_2_17_147_1","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/j.jaad.2020.12.074","article-title":"Contrast\u2010enhanced ultrasound with peroxide hydrogen for hidradenitis suppurativa and pilonidal sinus presurgical mapping","volume":"88","author":"Garc\u00eda\u2010Mart\u00ednez FJ","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"e_1_2_17_148_1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/DSS.0000000000000379","article-title":"Utility of MRI in the diagnosis and post\u2010treatment evaluation of Anogenital hidradenitis Suppurativa","volume":"41","author":"Virgilio E","year":"2015","journal-title":"Dermatol Surg"},{"issue":"2","key":"e_1_2_17_149_1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000495982","article-title":"Long\u2010wave medical infrared thermography: A clinical biomarker of inflammation in hidradenitis Suppurativa\/acne Inversa","volume":"235","author":"Zouboulis CC","year":"2019","journal-title":"Dermatology"},{"issue":"1","key":"e_1_2_17_150_1","first-page":"32","article-title":"The findings of 18F\u2010fluorodeoxyglucose positron emission tomography\u2010computed tomography scan in patients with hidradenitis suppurativa in Malaysia: A multicenter study","volume":"20","author":"Loo C","year":"2020","journal-title":"World J Nucl Med"},{"issue":"2","key":"e_1_2_17_151_1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/bjd.18093","article-title":"Associations of cutaneous and extracutaneous infections with hidradenitis suppurativa in US children and adults","volume":"182","author":"Lee HH","year":"2020","journal-title":"Br J Dermatol"},{"key":"e_1_2_17_152_1","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12B+<2817::AID-CNCR32>3.0.CO;2-2","article-title":"Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma","volume":"83","author":"Passik SD","year":"1998","journal-title":"Cancer"},{"issue":"7","key":"e_1_2_17_153_1","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/pon.3201","article-title":"Psychosocial impact of lymphedema: A systematic review of literature from 2004 to 2011","volume":"22","author":"Fu MR","year":"2013","journal-title":"Psychooncology"},{"issue":"12","key":"e_1_2_17_154_1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/ijd.14173","article-title":"Lymphedema in patients with hidradenitis suppurativa: A systematic review of published literature","volume":"57","author":"Micieli R","year":"2018","journal-title":"Int J Dermatol"},{"issue":"6","key":"e_1_2_17_155_1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jaad.2017.03.022","article-title":"Lymphedema: Pathophysiology and clinical manifestations","volume":"77","author":"Grada AA","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"e_1_2_17_156_1","first-page":"25","article-title":"Cutaneous squamous cell carcinoma complicating hidradenitis suppurativa: A review of the prevalence, pathogenesis, and treatment of this dreaded complication","volume":"27","author":"Chapman S","year":"2018","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"11","key":"e_1_2_17_157_1","first-page":"1594","article-title":"Neoplastic implications in patients suffering from hidradenitis Suppurativa under systemic treatments","volume":"9","author":"Li Pomi F","year":"2021","journal-title":"Biomedicine"},{"issue":"2","key":"e_1_2_17_158_1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/iwj.12671","article-title":"Squamous cell carcinoma complicating a chronic lesion of hidradenitis suppurativa: A case report and review of the literature","volume":"14","author":"Jourabchi N","year":"2017","journal-title":"Int Wound J"},{"issue":"11","key":"e_1_2_17_159_1","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.1111\/ijd.15677","article-title":"Squamous cell carcinoma arising within hidradenitis suppurativa: A literature review","volume":"60","author":"Sachdeva M","year":"2021","journal-title":"Int J Dermatol"},{"issue":"4","key":"e_1_2_17_160_1","article-title":"Squamous cell carcinoma in the setting of chronic hidradenitis suppurativa; report of a patient and update of the literature","volume":"21","author":"Pena ZG","year":"2015","journal-title":"Dermatol Online J"},{"issue":"8","key":"e_1_2_17_161_1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jamadermatol.2020.1422","article-title":"Assessment of overall and specific cancer risks in patients with hidradenitis Suppurativa","volume":"156","author":"Jung JM","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"2","key":"e_1_2_17_162_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.12788\/j.sder.2017.022","article-title":"Complications of hidradenitis suppurativa","volume":"36","author":"Yuan JT","year":"2017","journal-title":"Semin Cutan Med Surg"},{"issue":"4","key":"e_1_2_17_163_1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamadermatol.2020.5857","article-title":"Expert knowledge, attitudes, and practices in Management of Hidradenitis Suppurativa Pain","volume":"157","author":"Jedrzejczak MJ","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"5","key":"e_1_2_17_164_1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ced.14186","article-title":"Amyloidosis in hidradenitis suppurativa: A cross\u2010sectional study and review of the literature","volume":"45","author":"Kridin K","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"e_1_2_17_165_1","first-page":"33","article-title":"Hidradenitis Suppurativa: A lesser\u2010known cause of AA amyloidosis","volume":"24","author":"Helvac\u0131 \u00d6","year":"2020","journal-title":"Hippokratia"},{"issue":"12","key":"e_1_2_17_166_1","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/imj.15974","article-title":"Current approaches to the diagnosis and management of amyloidosis","volume":"52","author":"Taylor MS","year":"2022","journal-title":"Intern Med J"},{"issue":"3","key":"e_1_2_17_167_1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/ced.12731","article-title":"Severe hidradenitis suppurativa complicated by renal AA amyloidosis","volume":"41","author":"Utrera\u2010Busquets M","year":"2016","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"e_1_2_17_168_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijwd.2020.02.006","article-title":"Integrated multidisciplinary approach to hidradenitis suppurativa in clinical practice","volume":"6","author":"Timila Touhouche A","year":"2020","journal-title":"Int J Womens Dermatol"},{"issue":"4","key":"e_1_2_17_169_1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/SAP.0000000000002105","article-title":"Factors affecting healing in the treatment of hidradenitis Suppurativa","volume":"84","author":"Worden A","year":"2020","journal-title":"Ann Plast Surg"},{"key":"e_1_2_17_170_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-540-33101-8_4","volume-title":"Hidradenitis Suppurativa","author":"Layton A","year":"2006"},{"issue":"6","key":"e_1_2_17_171_1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2133.1990.tb06264.x","article-title":"Hidradenitis suppurativa: A disease of follicular epithelium, rather than apocrine glands","volume":"122","author":"Yu C","year":"1990","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"e_1_2_17_172_1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0190-9622(96)90277-7","article-title":"Histology of hidradenitis suppurativa","volume":"34","author":"Jemec GBE","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"e_1_2_17_173_1","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/exd.14398","article-title":"Yin and Yang: A disrupted skin microbiome and an aberrant host immune response in hidradenitis suppurativa","volume":"30","author":"Schell SL","year":"2021","journal-title":"Exp Dermatol"},{"issue":"2","key":"e_1_2_17_174_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","article-title":"Hidradenitis suppurativa\/acne inversa: Bilocated epithelial hyperplasia with very different sequelae","volume":"164","author":"Laffert M","year":"2011","journal-title":"Br J Dermatol"},{"issue":"11","key":"e_1_2_17_175_1","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","article-title":"Hidradenitis Suppurativa is characterized by dysregulation of the Th17:Treg cell Axis, which is corrected by anti\u2010TNF therapy","volume":"137","author":"Moran B","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"508","key":"e_1_2_17_176_1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5908","article-title":"Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa","volume":"11","author":"Byrd AS","year":"2019","journal-title":"Sci Transl Med"},{"issue":"4","key":"e_1_2_17_177_1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/jdv.16147","article-title":"Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa","volume":"34","author":"Zouboulis CC","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"19","key":"e_1_2_17_178_1","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139932","article-title":"Immunopathogenesis of hidradenitis suppurativa and response to anti\u2013TNF\u2010\u03b1 therapy","volume":"5","author":"Lowe MM","year":"2020","journal-title":"JCI Insight"},{"issue":"1","key":"e_1_2_17_179_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2021.100001","article-title":"Hidradenitis Suppurativa: Host\u2010microbe and immune pathogenesis underlie important future directions","volume":"1","author":"Jiang SW","year":"2021","journal-title":"JID Innov"},{"issue":"4","key":"e_1_2_17_180_1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/bjd.18556","article-title":"Interleukin 17C is elevated in lesional tissue of hidradenitis suppurativa","volume":"182","author":"Navrazhina K","year":"2020","journal-title":"Br J Dermatol"},{"issue":"5","key":"e_1_2_17_181_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jmg.22.5.367","article-title":"A family study of hidradenitis suppurativa","volume":"22","author":"Fitzsimmons JS","year":"1985","journal-title":"J Med Genet"},{"issue":"3","key":"e_1_2_17_182_1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","article-title":"Hidradenitis suppurativa: A retrospective study of 846 Dutch patients to identify factors associated with disease severity","volume":"71","author":"Schrader AMR","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"e_1_2_17_183_1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/bjd.20654","article-title":"Evidence of gene\u2013gene interaction in hidradenitis suppurativa: A nationwide registry study of Danish twins","volume":"186","author":"Kj\u00e6rsgaard Andersen R","year":"2022","journal-title":"Br J Dermatol"},{"issue":"12","key":"e_1_2_17_184_1","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamadermatol.2020.3630","article-title":"Contribution of genetics to the susceptibility to hidradenitis Suppurativa in a large, cross\u2010sectional Dutch twin cohort","volume":"156","author":"Straalen KR","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"10","key":"e_1_2_17_185_1","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/jid.2012.162","article-title":"Mutations in the \u03b3\u2010secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa)","volume":"132","author":"Pink AE","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"10","key":"e_1_2_17_186_1","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.jid.2019.10.025","article-title":"Low prevalence of GSC gene mutations in a large cohort of predominantly Caucasian patients with hidradenitis Suppurativa","volume":"140","author":"Duchatelet S","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"6007","key":"e_1_2_17_187_1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.1196284","article-title":"Gamma\u2010secretase gene mutations in familial acne Inversa","volume":"330","author":"Wang B","year":"2010","journal-title":"Science"},{"issue":"5931","key":"e_1_2_17_188_1","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1171700","article-title":"Topographical and temporal diversity of the human skin microbiome","volume":"324","author":"Grice EA","year":"2009","journal-title":"Science"},{"issue":"7520","key":"e_1_2_17_189_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13786","article-title":"Biogeography and individuality shape function in the human skin metagenome","volume":"514","author":"Oh J","year":"2014","journal-title":"Nature"},{"issue":"4","key":"e_1_2_17_190_1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jid.2018.10.020","article-title":"Apocrine gland\u2013rich skin has a non\u2010inflammatory IL\u201017\u2013related immune milieu, that turns to inflammatory IL\u201017\u2013mediated disease in hidradenitis Suppurativa","volume":"139","author":"Jenei A","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"1","key":"e_1_2_17_191_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jid.2018.09.036","article-title":"Are bacteria infectious pathogens in hidradenitis Suppurativa? Debate at the symposium for hidradenitis Suppurativa advances meeting, November 2017","volume":"139","author":"Naik HB","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"3","key":"e_1_2_17_192_1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jid.2019.06.151","article-title":"Loss of skin microbial diversity and alteration of bacterial metabolic function in hidradenitis Suppurativa","volume":"140","author":"Schneider AM","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"9","key":"e_1_2_17_193_1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","article-title":"The follicular skin microbiome in patients with hidradenitis Suppurativa and healthy controls","volume":"153","author":"Ring HC","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"4","key":"e_1_2_17_194_1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jid.2019.08.445","article-title":"Skin microbiota perturbations are distinct and disease severity\u2010dependent in hidradenitis Suppurativa","volume":"140","author":"Naik HB","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"9","key":"e_1_2_17_195_1","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jdv.15597","article-title":"The microbiome of tunnels in hidradenitis suppurativa patients","volume":"33","author":"Ring HC","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"e_1_2_17_196_1","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.jid.2020.02.046","article-title":"The surface microbiome of clinically unaffected skinfolds in hidradenitis Suppurativa: A cross\u2010sectional culture\u2010based and 16S rRNA gene amplicon Sequencing study in 60 patients","volume":"140","author":"Riverain\u2010Gillet \u00c9","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"12","key":"e_1_2_17_197_1","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3201\/eid2012.140064","article-title":"Bacterial pathogens associated with hidradenitis Suppurativa","volume":"20","author":"Guet\u2010Revillet H","year":"2014","journal-title":"France Emerg Infect Dis"},{"issue":"2","key":"e_1_2_17_198_1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cid\/cix285","article-title":"The microbiological landscape of anaerobic infections in hidradenitis Suppurativa: A prospective metagenomic study","volume":"65","author":"Guet\u2010Revillet H","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"e_1_2_17_199_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1574-695X.2012.00946.x","article-title":"Considering hidradenitis suppurativa as a bacterial biofilm disease","volume":"65","author":"Kathju S","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"e_1_2_17_200_1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/bjd.15007","article-title":"Bacterial biofilm in chronic lesions of hidradenitis suppurativa","volume":"176","author":"Ring HC","year":"2017","journal-title":"Br J Dermatol"},{"key":"e_1_2_17_201_1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.960488","article-title":"Innate immunity and microbial dysbiosis in hidradenitis suppurativa \u2010 vicious cycle of chronic inflammation","volume":"13","author":"Chopra D","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"e_1_2_17_202_1","doi-asserted-by":"crossref","first-page":"e731","DOI":"10.1111\/jdv.18254","article-title":"Culture\u2010based analyses of skin bacteria in lesional moist, and unaffected dry and sebaceous skin regions of hidradenitis suppurativa patients","volume":"36","author":"Antal D","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"e_1_2_17_203_1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2340\/00015555-2503","article-title":"Normal skin microbiota is altered in pre\u2010clinical hidradenitis Suppurativa","volume":"97","author":"Ring HC","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"e_1_2_17_204_1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen TH","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"e_1_2_17_205_1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm.2062","article-title":"Commensal bacteria regulate toll\u2010like receptor 3\u2010dependent inflammation after skin injury","volume":"15","author":"Lai Y","year":"2009","journal-title":"Nat Med"},{"issue":"5","key":"e_1_2_17_206_1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2133.2011.10765.x","article-title":"Immunohistological pointers to a possible role for excessive cathelicidin (LL\u201037) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa\/acne inversa","volume":"166","author":"Emelianov VU","year":"2012","journal-title":"Br J Dermatol"},{"issue":"9","key":"e_1_2_17_207_1","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jid.2016.04.036","article-title":"Intrinsic defect in keratinocyte function leads to inflammation in hidradenitis Suppurativa","volume":"136","author":"Hotz C","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"10","key":"e_1_2_17_208_1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00011-020-01381-7","article-title":"Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis","volume":"69","author":"Rumberger BE","year":"2020","journal-title":"Inflamm Res"},{"issue":"3","key":"e_1_2_17_209_1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/all.13665","article-title":"Novel cytokine and chemokine markers of hidradenitis suppurativa reflect chronic inflammation and itch","volume":"74","author":"Vossen AR","year":"2019","journal-title":"Allergy"},{"issue":"3","key":"e_1_2_17_210_1","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820942646","article-title":"Identification of hidradenitis Suppurativa\u2010related mRNA expression patterns through analysis of gene expression omnibus","volume":"18","author":"Teng Y","year":"2020","journal-title":"Dose Response"},{"issue":"3","key":"e_1_2_17_211_1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/jdv.17779","article-title":"Primary alterations during the development of hidradenitis suppurativa","volume":"36","author":"Dajnoki Z","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"e_1_2_17_212_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","article-title":"Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa","volume":"149","author":"Sartorius K","year":"2003","journal-title":"Br J Dermatol"},{"issue":"2","key":"e_1_2_17_213_1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/09546634.2017.1341614","article-title":"Development and initial psychometric evaluation of patient\u2010reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa","volume":"29","author":"Kimball AB","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"e_1_2_17_214_1","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/jdv.16132","article-title":"Baseline patient\u2010reported outcomes from UNITE: An observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice","volume":"34","author":"Kimball AB","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"e_1_2_17_215_1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double\u2010blind, placebo\u2010controlled crossover trial","volume":"62","author":"Grant A","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"e_1_2_17_216_1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1365-4632.2010.04545.x","article-title":"A prospective open\u2010label clinical trial of adalimumab for the treatment of hidradenitis suppurativa","volume":"49","author":"Amano M","year":"2010","journal-title":"Int J Dermatol"},{"issue":"10","key":"e_1_2_17_217_1","first-page":"258","article-title":"AISI: A new disease severity assessment tool for hidradenitis Suppurativa","volume":"27","author":"Chiricozzi A","year":"2015","journal-title":"Wounds"},{"issue":"8","key":"e_1_2_17_218_1","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2016-210901","article-title":"Autoinflammatory disease damage index (ADDI): A possible newborn also in hidradenitis suppurativa daily practice","volume":"76","author":"Damiani G","year":"2017","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70638","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.70638","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:14:00Z","timestamp":1787058840000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.70638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":217,"alternative-id":["10.1111\/jdv.70638"],"URL":"https:\/\/doi.org\/10.1111\/jdv.70638","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"2025-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"jdv.70638"}}